Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Curr Gastroenterol Rep. 2010 Dec;12(6):471-8. doi: 10.1007/s11894-010-0146-8.

Mucosal healing in inflammatory bowel disease: where do we stand?

Author information

  • 1Division of Gastroenterology and Hepatology, The Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. christina.ha@jhmi.edu

Abstract

The definition of remission in Crohn's disease and ulcerative colitis has evolved to include mucosal healing as a measure of treatment efficacy. Randomized, controlled trials have demonstrated mucosal healing is attainable with the current arsenal of therapies available to treat inflammatory bowel disease. Mucosal healing has been shown to reduce the likelihood of clinical relapse, reduce the risk of future surgeries, and reduce hospitalizations. This review focuses on the latest studies addressing clinical outcomes of mucosal healing in the clinical trial and practice setting.

PMID:
20886319
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk